ROBERT LENTZ: Open Payments
NPI 1720001225 · GREENACRES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 29 payments from 5 companies in 2025. Trend: 2023 $52 · 2024 $150 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $267 |
| ABBVIE INC. | 4 | $83 |
| PROTEGA PHARMACEUTIALS INC | 4 | $76 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Forte Bio-Pharma LLC | 2 | $33 |
Products named: RELISTOR, ROXYBOND, QULIPTA, Belbuca, PROLATE, UBRELVY, BOTOX.
Industry payments across FL — which companies pay providers there.
